A phase I study investigating the absorption, metabolism, and excretion of [14C] anlotinib in patients with advanced refractory solid tumors

被引:0
作者
Liu, Yiqian
Xu, Tongpeng
Liu, Lianke
Shu, Yongqian
机构
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Nanjing, Jiangsu, Peoples R China
关键词
D O I
10.1200/JCO.2019.37.15_suppl.e14701
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e14701
引用
收藏
页数:1
相关论文
empty
未找到相关数据